EV targets nectin-4 to deliver the cytotoxic agent MMAE into cancer cells, where MMAE disrupts microtubule polymerization in keratinocytes, inducing apoptosis or necrosis and achieving a tumor-specific antitumor effect. The gene discussed is NECTIN4; the disease is cancer.